Literature DB >> 28923875

Pharmacological Inhibition of the Pseudomonas aeruginosa MvfR Quorum-Sensing System Interferes with Biofilm Formation and Potentiates Antibiotic-Mediated Biofilm Disruption.

Damien Maura1, Laurence G Rahme1.   

Abstract

Pseudomonas aeruginosa biofilms contribute to its survival on biotic and abiotic surfaces and represent a major clinical threat due to their high tolerance to antibiotics. Therefore, the discovery of antibiofilm agents may hold great promise. We show that pharmacological inhibition of the P. aeruginosa quorum-sensing regulator MvfR (PqsR) using a benzamide-benzimidazole compound interferes with biofilm formation and potentiates biofilm sensitivity to antibiotics. Such a strategy could have great potential against P. aeruginosa persistence in diverse environments.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  M64; MvfR; PqsR; Pseudomonas aeruginosa; antibiotic adjuvant; antibiotic potentiation; antibiotic tolerance; antivirulence; biofilm

Mesh:

Substances:

Year:  2017        PMID: 28923875      PMCID: PMC5700327          DOI: 10.1128/AAC.01362-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication.

Authors:  Eric Déziel; François Lépine; Sylvain Milot; Jianxin He; Michael N Mindrinos; Ronald G Tompkins; Laurence G Rahme
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

3.  Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening.

Authors:  Joe J Harrison; Carol A Stremick; Raymond J Turner; Nick D Allan; Merle E Olson; Howard Ceri
Journal:  Nat Protoc       Date:  2010-06-10       Impact factor: 13.491

4.  A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms.

Authors:  Marie Allesen-Holm; Kim Bundvig Barken; Liang Yang; Mikkel Klausen; Jeremy S Webb; Staffan Kjelleberg; Søren Molin; Michael Givskov; Tim Tolker-Nielsen
Journal:  Mol Microbiol       Date:  2006-02       Impact factor: 3.501

5.  Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  Glenn A Pankuch; Gengrong Lin; Harald Seifert; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

Review 6.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

7.  Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation.

Authors:  Liang Yang; Martin Nilsson; Morten Gjermansen; Michael Givskov; Tim Tolker-Nielsen
Journal:  Mol Microbiol       Date:  2009-11-02       Impact factor: 3.501

8.  Auto Poisoning of the Respiratory Chain by a Quorum-Sensing-Regulated Molecule Favors Biofilm Formation and Antibiotic Tolerance.

Authors:  Ronen Hazan; Yok Ai Que; Damien Maura; Benjamin Strobel; Paul Anthony Majcherczyk; Laura Rose Hopper; David J Wilbur; Teri N Hreha; Blanca Barquera; Laurence G Rahme
Journal:  Curr Biol       Date:  2016-01-14       Impact factor: 10.834

Review 9.  Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review.

Authors:  Felix Ratjen; Florian Brockhaus; Gerhild Angyalosi
Journal:  J Cyst Fibros       Date:  2009-09-10       Impact factor: 5.482

Review 10.  The clinical impact of bacterial biofilms.

Authors:  Niels Høiby; Oana Ciofu; Helle Krogh Johansen; Zhi-jun Song; Claus Moser; Peter Østrup Jensen; Søren Molin; Michael Givskov; Tim Tolker-Nielsen; Thomas Bjarnsholt
Journal:  Int J Oral Sci       Date:  2011-04       Impact factor: 6.344

View more
  25 in total

Review 1.  Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients.

Authors:  Elana Shaw; William M Wuest
Journal:  RSC Med Chem       Date:  2020-02-19

Review 2.  The State of the Union Is Strong: a Review of ASM's 6th Conference on Cell-Cell Communication in Bacteria.

Authors:  Sam P Brown; Helen E Blackwell; Brian K Hammer
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

Review 3.  Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective.

Authors:  Benjamin Rémy; Sonia Mion; Laure Plener; Mikael Elias; Eric Chabrière; David Daudé
Journal:  Front Pharmacol       Date:  2018-03-07       Impact factor: 5.810

4.  Hit Identification of New Potent PqsR Antagonists as Inhibitors of Quorum Sensing in Planktonic and Biofilm Grown Pseudomonas aeruginosa.

Authors:  Fadi Soukarieh; Ruiling Liu; Manuel Romero; Shaun N Roberston; William Richardson; Simone Lucanto; Eduard Vico Oton; Naim Ruhul Qudus; Alaa Mashabi; Scott Grossman; Sadiqur Ali; Tomás Sou; Irena Kukavica-Ibrulj; Roger C Levesque; Christel A S Bergström; Nigel Halliday; Shailesh N Mistry; Jonas Emsley; Stephan Heeb; Paul Williams; Miguel Cámara; Michael J Stocks
Journal:  Front Chem       Date:  2020-05-04       Impact factor: 5.221

Review 5.  Targeting the Pseudomonas quinolone signal quorum sensing system for the discovery of novel anti-infective pathoblockers.

Authors:  Christian Schütz; Martin Empting
Journal:  Beilstein J Org Chem       Date:  2018-10-15       Impact factor: 2.883

6.  Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa.

Authors:  Francesca D'Angelo; Valerio Baldelli; Nigel Halliday; Paolo Pantalone; Fabio Polticelli; Ersilia Fiscarelli; Paul Williams; Paolo Visca; Livia Leoni; Giordano Rampioni
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

7.  Antimicrobial Peptide Dendrimers and Quorum-Sensing Inhibitors in Formulating Next-Generation Anti-Infection Cell Therapy Dressings for Burns.

Authors:  Paris Jafari; Alexandre Luscher; Thissa Siriwardena; Murielle Michetti; Yok-Ai Que; Laurence G Rahme; Jean-Louis Reymond; Wassim Raffoul; Christian Van Delden; Lee Ann Applegate; Thilo Köhler
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

8.  Spatiotemporal Distribution of Pseudomonas aeruginosa Alkyl Quinolones under Metabolic and Competitive Stress.

Authors:  Tianyuan Cao; Jonathan V Sweedler; Paul W Bohn; Joshua D Shrout
Journal:  mSphere       Date:  2020-07-22       Impact factor: 4.389

9.  In Silico and in Vitro-Guided Identification of Inhibitors of Alkylquinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa.

Authors:  Fadi Soukarieh; Eduard Vico Oton; Jean-Frédéric Dubern; Janice Gomes; Nigel Halliday; Maria de Pilar Crespo; Jonathan Ramírez-Prada; Braulio Insuasty; Rodrigo Abonia; Jairo Quiroga; Stephan Heeb; Paul Williams; Michael J Stocks; Miguel Cámara
Journal:  Molecules       Date:  2018-01-28       Impact factor: 4.411

10.  A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms.

Authors:  Christian Schütz; Duy-Khiet Ho; Mostafa Mohamed Hamed; Ahmed Saad Abdelsamie; Teresa Röhrig; Christian Herr; Andreas Martin Kany; Katharina Rox; Stefan Schmelz; Lorenz Siebenbürger; Marius Wirth; Carsten Börger; Samir Yahiaoui; Robert Bals; Andrea Scrima; Wulf Blankenfeldt; Justus Constantin Horstmann; Rebekka Christmann; Xabier Murgia; Marcus Koch; Aylin Berwanger; Brigitta Loretz; Anna Katharina Herta Hirsch; Rolf Wolfgang Hartmann; Claus-Michael Lehr; Martin Empting
Journal:  Adv Sci (Weinh)       Date:  2021-03-18       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.